Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeJason Coppell, Dietger Niederwieser, Massimo Iacobelli et al.|Biology of Blood and Marrow Transplantation|2009Cited by 595
RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34 <sup>+</sup> Cells in Patients Undergoing Transplantation for AIDS-Related LymphomaDavid DiGiusto, John A. Zaia, Amrita Krishnan et al.|Science Translational Medicine|2010Cited by 376
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F. Herrera, Philippe Armand, Matthew Mei et al.|Journal of Clinical Oncology|2016Cited by 187
Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I StudySuzanne Trudel, Simon J. Harrison, Adam D. Cohen et al.|Blood|2021Cited by 161
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Idit Shachar, Emine Gulsen Gunes et al.|JCI Insight|2021Cited by 64